A Retrospective Data Collection on NobelProcera® Zirconia Implant Bridges from 4 to 14 Units.
Launched by NOBEL BIOCARE · Sep 13, 2024
Trial Information
Current as of June 30, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a type of dental bridge called the NobelProcera® Zirconia Implant Bridge, which is used to replace missing teeth. The study is collecting information from patients who have received these bridges, which can have between 4 to 14 units, to evaluate how safe and effective they are in everyday dental practice. Researchers are gathering data from about 150 to 200 patients across multiple dental centers to learn more about the performance of these bridges.
To participate in this study, you need to be at least 18 years old and have received at least one NobelProcera® Zirconia Implant Bridge supported by two to ten implants. There are no specific health conditions that would exclude you from participating. If you're eligible, your experiences and clinical information will help researchers understand the benefits of these dental implants better. It's important to note that the trial is currently active, but it is not recruiting new participants at this time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subject was at least 18 years old at the time of treatment,
- • Subjects treated with at least one NobelProcera® Zirconia Implant Bridge (4- to 14-unit supported by 2 to 10 implants).
- Exclusion Criteria:
- • none
About Nobel Biocare
Nobel Biocare is a leading global provider of innovative dental solutions, specializing in implant-based restorative dentistry. With a commitment to advancing oral health and enhancing patient outcomes, the company develops cutting-edge technologies, including implants, prosthetics, and digital workflows, supported by extensive research and clinical evidence. Nobel Biocare collaborates with dental professionals worldwide to deliver high-quality products and services that are designed to meet the evolving needs of practitioners and their patients, ultimately contributing to the enhancement of dental care standards across the industry.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kloten, , Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported